Halaman 4 - Skrining kanker Dokter Terbaik - TOP-118 dokter

Dokter adalah seorang ahli onkologi medis dan internis Austria yang terkemuka dengan pengalaman lebih dari dua dekade, yang berspesialisasi dalam kanker payudara, keganasan ginekologi, dan terapi kanker yang ditargetkan. Lulusan Universitas Wina, dokter menyelesaikan residensi dalam bidang penyakit dalam dan onkologi medis di Universitas Kedokteran Wina. Dokter telah berkontribusi pada uji klinis awal tentang terapi yang ditargetkan dan merupakan otoritas terkemuka dalam pengobatan kanker yang dipersonalisasi.<\/p>

Saat ini menjabat sebagai konsultan senior di Wiener Privatklinik dan melanjutkan pekerjaan akademis di Universitas Kedokteran Wina, dokter berfokus pada terapi kanker sistemik yang dipersonalisasi, imunoterapi, dan penelitian kanker translasi. Penelitian dokter mencakup pengembangan biomarker dan mekanisme resistensi terhadap obat yang ditargetkan, dengan publikasi di jurnal internasional terkemuka.<\/p>

Dokter adalah seorang ahli bedah toraks terkenal yang diakui atas pekerjaan perintisnya dalam transplantasi paru-paru dan onkologi toraks. Dengan pengalaman puluhan tahun, dokter telah menjadikan Wina sebagai pusat global untuk operasi paru-paru tingkat lanjut.<\/p>

Setelah belajar kedokteran di Universitas Wina pada tahun 1970-an, dokter mengkhususkan diri dalam bedah toraks dan kardiovaskular, dengan fokus pada penyakit paru-paru yang parah. Pada tahun 1980-an, menyelesaikan pelatihan spesialis di Rumah Sakit Umum Wina dan melakukan salah satu transplantasi paru-paru pertama di Austria pada tahun 1989.<\/p>

Pada tahun 2000-an, menjadi Kepala Departemen Bedah Toraks di Universitas Kedokteran Wina. Dokter terus memimpin inovasi dalam onkologi toraks dan kedokteran transplantasi.<\/p>

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Dokter adalah seorang ahli onkologi yang berspesialisasi dalam pengobatan kanker payudara, paru-paru, dan saluran pencernaan. Saat ini, dokter berpraktik di Rumah Sakit Universitas Istinye Liv.

Dengan karier yang mencakup berbagai institusi terkemuka, dokter telah bertugas sebagai Spesialis Penyakit Dalam di Rumah Sakit Negara Malatya, dokter di Klinik Onkologi Ankara, dan anggota Departemen Onkologi di Rumah Sakit Pelatihan dan Penelitian Regional Erzurum.

Dokter lulus dari Fakultas Kedokteran Universitas Selcuk dan meraih gelar Associate Professor pada tahun 2016.

Dr. Victor Alexander Krol - Kepala Gastroenterologi, Penyakit Dalam dan Pusat Pengobatan Obesitas di Rumah Sakit Martinus

Dr. Victor Alexander Krol adalah seorang spesialis yang sangat berkualifikasi, memimpin departemen gastroenterologi dan penyakit dalam. Dengan pengalaman bertahun-tahun dan pengetahuan mendalam di bidangnya, Dr. Krol telah membuktikan dirinya sebagai ahli luar biasa, memberikan perawatan komprehensif dan pendekatan individual kepada pasien. Dia secara aktif menggunakan metode terbaru dalam diagnosis dan pengobatan penyakit saluran pencernaan, metabolisme, serta penyakit sistem kardiovaskular dan pernapasan.

Dr. Krol juga merupakan direktur Pusat Pengobatan Obesitas bersertifikat di Rumah Sakit Martinus, yang menyediakan perawatan bedah dan endoskopi untuk obesitas. Pusat ini menggunakan teknologi canggih untuk mendiagnosis dan mengobati obesitas (adiposis), termasuk metode seperti bedah bariatrik, penurunan berat badan endoskopi, dan program khusus untuk pasien dengan berbagai tahapan obesitas. Pusat ini bersertifikat dengan standar tinggi dan memiliki hasil yang sangat baik dalam pengobatan penyakit serius ini.

Departemen Gastroenterologi, yang dipimpin oleh Dr. Krol, mendiagnosis dan mengobati penyakit perut, usus, hati, pankreas, dan kantong empedu. Dokter di departemen ini menggunakan berbagai metode, termasuk prosedur endoskopi, ultrasound, dan teknologi diagnostik modern lainnya.

Departemen Penyakit Dalam mencakup berbagai penyakit, termasuk kardiologi, diabetologi, infektologi, dan terapi penyakit pernapasan serta ginjal. Dr. Krol dan timnya memberikan pendekatan komprehensif untuk pengobatan dengan menggunakan metode pengobatan paling maju.

Berkat profesionalismenya yang tinggi dan pendekatan humanis terhadap setiap pasien, Dr. Krol secara layak mendapatkan penghormatan dari rekan kerja dan pasien.

Lee Ji Hyun, MD, is a breast and thyroid surgeon. Dr. Lee is Head of Breast and Thyroid Surgery at Naeun Hospital. Clinical focus includes benign breast disease, breast cancer, and tumor surgery. Additional areas include benign thyroid disease, thyroid cancer, and parathyroid disorders. Skills include Mammotome procedures, axillary node management, and breast and thyroid ultrasound.

Education and training: Yonsei University College of Medicine. Internship and general surgery residency at Yonsei University Severance Hospital. Short-term clinical training at the Affiliated Hospital of the Cancer Research Institute in Japan.

Key roles: Chief of General Surgery at Incheon Christian Hospital and General Surgery Specialist at Cheil Hospital. Director of the Breast Center and Chief of the Department of Surgery at Samsung Cheil Hospital. Chief of General Surgery and Deputy Director of Clinical Services at Cheil Hospital. Outpatient Professor of Surgery at CHA Gangnam Medical Center, CHA University. Chief of General Surgery at Daejeong Hospital.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Dr. Qasim Wasim holds an MBBS and master’s and PhD degrees in general surgery from Dalian Medical University. He is a PMDC board-certified general practitioner with over 10 years of experience. He served as a resident at Shaikh Zayed Medical Complex and at Nawaz Sharif Social Security Hospital in Lahore.

He manages cases in internal medicine, general surgery, obstetrics and gynecology, pediatrics, and dermatology. He also handles emergencies such as trauma, fractures, cardiac events, and burns. He is multilingual and serves an international community. He has authored over eight SCI-indexed research papers on intestinal ischemia–reperfusion injury and surgical biomechanics.

Dokter adalah seorang Onkolog Medis dan Radioterapis dengan pengalaman 33 tahun, yang mengkhususkan diri dalam Onkologi dan Radioterapi. Mereka lulus dari Rumah Sakit Universitas Hadassah di Yerusalem, Israel, dan memiliki kualifikasi dalam Onkologi dan Radioterapi.<\/p>

Saat ini menjabat sebagai Kepala Pusat Kanker Gastrointestinal, dokter juga merupakan Dokter Senior di Departemen Onkologi di Rumah Sakit Universitas Hadassah. Mereka telah menyelesaikan ujian dewan dalam Onkologi dan Radioterapi, dan merupakan anggota dari beberapa masyarakat profesional, termasuk Masyarakat Onkologi Klinis Israel dan Asosiasi Kanker Israel.<\/p>

Dokter adalah pakar terkemuka dalam pengobatan limfoma non-Hodgkin dan mengkhususkan diri dalam pengobatan gangguan darah. Dengan lebih dari 30 tahun praktik, dokter memimpin sektor Hematologi di Klinik Nordwest, berfokus pada perawatan hematologi lanjutan dan penelitian.<\/p>

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.​

Education and Training:

Graduated in Medicine and Surgery from the University of Navarra (1985).​

Completed residency in Oncology in 1987.​

Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).​

Professional Experience:

Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).​

Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).​

Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).

Head of the Oncology Department at Hospital General de Villalba (2014–2019).​

Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.​

Certifications and Training:

Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.​

Research and Publications:

Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.

Dokter memimpin Pusat Melanoma dan Imunoterapi Kanker di Pusat Medis Hadassah, dengan fokus pada penelitian inovatif dan perawatan pasien. Mengkhususkan diri dalam studi keluarga reseptor SLAM, dokter berada di garis depan penelitian respons imun anti-kanker.<\/p>

Terlibat dalam merawat pasien melanoma dengan imunoterapi baru, dokter bekerja dengan tim klinisi dan peneliti. Kolaborasi ini memberikan akses langsung ke data klinis dan jaringan yang berasal dari pasien, meningkatkan upaya penelitian translasi.<\/p>